Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds

Journal of Medicinal Chemistry

Volumn 51, Issue 17, 2008, Pages 5342-5348

  Lounkine, Eugen ^a   Auer, Jens ^a   Bajorath, Jürgen ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; SEROTONIN 1 ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN ANTAGONIST;

ARTICLE; CHEMICAL STRUCTURE; CONCEPT ANALYSIS; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; FRAGMENT FORMAL CONCEPT ANALYSIS; FRAGMENTATION REACTION; HIGH THROUGHPUT SCREENING; METHODOLOGY;

ALGORITHMS; BIOGENIC AMINES; CATHEPSINS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; MODELS, CHEMICAL; MOLECULAR STRUCTURE; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 51849102040     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800515r     Document Type: Article

References (18)

1. Erlanson, D. A.; McDowell, R. S.; O'Brien, T. Fragment-Based Drug Discovery. J. Med. Chem. 2004, 47, 3463-3482.
2. Schnur, D. M.; Hermsmeier, M. A.; Tebben, A. J. Are Target-Family- Privileged Substructures Truly Privileged? J. Med. Chem. 2006, 49, 2000-2009.
3. Aronov, A. M.; McClain, B.; Moody, C. S.; Murcko, M. A. Kinase-Likeness and Kinase-Privileged Fragments: Toward Virtual Polypharmacology. J. Med. Chem. 2008, 51, 1214-1222.
4. Lameijer, E.; Kok, J. N.; Bäck, T.; Ijzerman, A. P. Mining a Chemical Database for Fragment Co-Occurrence: Discovery of "Chemical Clichés". J. Chem. Inf. Model. 2007, 46, 553-562.
5. Sutherland, J. J.; Higgs, R. E.; Watson, I.; Vieth, M. Chemical Fragments as Foundations for Understanding Target Space and Activity Prediction. J. Med. Chem. 2008, 51, 2689-2700.
6. Crisman, T. J.; Bender, A.; Milik, M.; Jenkins, J. L.; Scheiber, J.; Sukuru, S. C. K.; Fejzo, J.; Hommel, U.; Davies, J. W.; Glick, M. "Virtual Fragment Linking": An Approach To Identify Potent Binders from Low Affinity Fragment Hits. J. Med. Chem. 2008, 51, 2481-2491.
7. Wolohan, P. R. N.; Akella, L. B.; Dorfman, R. J.; Nell, P. G.; Mundt, S. M.; Clark, R. D. Structural Unit Analysis Identifies Lead Series and Facilitates Scaffold Hopping in Combinatorial Chemistry. J. Chem. Inf. Model. 2006, 46, 1188-1193.
8. Batista, J.; Bajorath, J. Mining of Randomly Generated Molecular Fragment Populations Uncovers Activity-Specific Fragment Hierarchies. J. Chem. Inf. Model. 2007, 47, 1405-1413.
9. Morphy, R.; Rankovic, Z. Designed Multiple Ligands. An Emerging Drug Discovery Paradigm. J. Med. Chem. 2005, 48, 6523-6543.
10. Sheridan, R. P. Finding Multiactivity Substructures by Mining Databases of Drug-like Compounds. J. Chem. Inf. Comput. Sci. 2003, 43, 1037-1050.
11. Priss, U. Formal Concept Analysis in Information Science. Annu. Rev. Inf. Sci. Technol. 2006, 40, 521-543.
12. Becker, P.; Hereth, J.; Stumme, G. ToscanaJ. An Open Source Tool for Qualitative Data Analysis. In Advances in Formal Concept Analysis for Knowledge Discovery in Databases, Proceedings Workshop FCAKDD of the 15th European Conference on Artificial Intelligence (ECAI), Lyon, France, 2002; Duquenne, V., Ganter, B., Liquiere, M., Nguifo, E. M., Stumme, G., Eds.; IOS Press: Amsterdam, 2002.
13. Vogt, I.; Ahmed, H.; Auer, J.; Bajorath, J. Exploring Structure-Selectivity Relationships of Biogenic Amine GPCR Antagonists Using Similarity Searching and Dynamic Compound Mapping. Mol. Diversity, in press; available online in the EarlyView section of the journal.
14. Stumpfe, D.; Ahmed, H. E.; Vogt, I.; Bajorath, J. Methods for computer-aided chemical biology. Part 1: Design of a benchmark system for the evaluation of compound selectivity. Chem. Biol. Drug Des. 2007, 70, 182-194.
15. Pubchem. http://pubchem.ncbi.nlm.nih.gov.
16. Bemis, G.; Murcko, M. The Properties of Known Drugs. 1. Molecular Frameworks. J. Med. Chem. 1996, 39, 2887-2893.
17. Molecular Operating Environment (MOE), version 2007.09; Chemical Computing Group Inc.: Montreal, Quebec, Canada, 2007; http://www.chemcomp.com (accessed Nov 1, 2007).
18. Molecular Drug Data Report (MDDR), version 2005.2; Symyx Software: San Ramon, USA.